These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

490 related items for PubMed ID: 30741731

  • 1. LONGITUDINAL CHANGES IN EYES WITH HYDROXYCHLOROQUINE RETINAL TOXICITY.
    Allahdina AM, Chen KG, Alvarez JA, Wong WT, Chew EY, Cukras CA.
    Retina; 2019 Mar; 39(3):473-484. PubMed ID: 30741731
    [Abstract] [Full Text] [Related]

  • 2. Effect of disease stage on progression of hydroxychloroquine retinopathy.
    Marmor MF, Hu J.
    JAMA Ophthalmol; 2014 Sep; 132(9):1105-12. PubMed ID: 24922444
    [Abstract] [Full Text] [Related]

  • 3. SEQUENTIAL CHANGES IN HYDROXYCHLOROQUINE RETINOPATHY UP TO 20 YEARS AFTER STOPPING THE DRUG: Implications for Mild Versus Severe Toxicity.
    Pham BH, Marmor MF.
    Retina; 2019 Mar; 39(3):492-501. PubMed ID: 30550532
    [Abstract] [Full Text] [Related]

  • 4. Quantitative assessment of outer retinal layers and ellipsoid zone mapping in hydroxychloroquine retinopathy.
    Ugwuegbu O, Uchida A, Singh RP, Beven L, Hu M, Kaiser S, Srivastava SK, Ehlers JP.
    Br J Ophthalmol; 2019 Jan; 103(1):3-7. PubMed ID: 30190364
    [Abstract] [Full Text] [Related]

  • 5. Fluorescence Lifetimes in Patients With Hydroxychloroquine Retinopathy.
    Solberg Y, Dysli C, Möller B, Wolf S, Zinkernagel MS.
    Invest Ophthalmol Vis Sci; 2019 May 01; 60(6):2165-2172. PubMed ID: 31108547
    [Abstract] [Full Text] [Related]

  • 6. Swept source optical coherence tomography angiography in patients treated with hydroxychloroquine: correlation with morphological and functional tests.
    Forte R, Haulani H, Dyrda A, Jürgens I.
    Br J Ophthalmol; 2021 Sep 01; 105(9):1297-1301. PubMed ID: 30842084
    [Abstract] [Full Text] [Related]

  • 7. Early hydroxychloroquine retinopathy: optical coherence tomography abnormalities preceding Humphrey visual field defects.
    Garrity ST, Jung JY, Zambrowski O, Pichi F, Su D, Arya M, Waheed NK, Duker JS, Chetrit Y, Miserocchi E, Giuffrè C, Kaden TR, Querques G, Souied EH, Freund KB, Sarraf D.
    Br J Ophthalmol; 2019 Nov 01; 103(11):1600-1604. PubMed ID: 30819690
    [Abstract] [Full Text] [Related]

  • 8. En Face Optical Coherence Tomography Imaging of the Photoreceptor Layers in Hydroxychloroquine Retinopathy.
    Ahn SJ, Joung J, Lee BR.
    Am J Ophthalmol; 2019 Mar 01; 199():71-81. PubMed ID: 30448463
    [Abstract] [Full Text] [Related]

  • 9. TOXIC EFFECTS OF HYDROXYCHLOROQUINE ON THE CHOROID: Evidence From Multimodal Imaging.
    Ahn SJ, Ryu SJ, Lim HW, Lee BR.
    Retina; 2019 May 01; 39(5):1016-1026. PubMed ID: 29373341
    [Abstract] [Full Text] [Related]

  • 10. Impact of Structural Changes on Multifocal Electroretinography in Patients With Use of Hydroxychloroquine.
    Borrelli E, Battista M, Cascavilla ML, Viganò C, Borghesan F, Nicolini N, Clemente L, Sacconi R, Barresi C, Marchese A, Miserocchi E, Modorati G, Bandello F, Querques G.
    Invest Ophthalmol Vis Sci; 2021 Sep 02; 62(12):28. PubMed ID: 34581725
    [Abstract] [Full Text] [Related]

  • 11. Long-Term Progression of Pericentral Hydroxychloroquine Retinopathy.
    Ahn SJ, Seo EJ, Kim KE, Kim YJ, Lee BR, Kim JG, Yoon YH, Lee JY.
    Ophthalmology; 2021 Jun 02; 128(6):889-898. PubMed ID: 33129843
    [Abstract] [Full Text] [Related]

  • 12. Disparity between visual fields and optical coherence tomography in hydroxychloroquine retinopathy.
    Marmor MF, Melles RB.
    Ophthalmology; 2014 Jun 02; 121(6):1257-62. PubMed ID: 24439759
    [Abstract] [Full Text] [Related]

  • 13. Quantitative Fundus Autofluorescence in HCQ Retinopathy.
    Greenstein VC, Lima de Carvalho JR, Parmann R, Amaro-Quireza L, Lee W, Hood DC, Tsang SH, Sparrow JR.
    Invest Ophthalmol Vis Sci; 2020 Sep 01; 61(11):41. PubMed ID: 32976563
    [Abstract] [Full Text] [Related]

  • 14. Progression of hydroxychloroquine toxic effects after drug therapy cessation: new evidence from multimodal imaging.
    Mititelu M, Wong BJ, Brenner M, Bryar PJ, Jampol LM, Fawzi AA.
    JAMA Ophthalmol; 2013 Sep 01; 131(9):1187-97. PubMed ID: 23887202
    [Abstract] [Full Text] [Related]

  • 15. Optical coherence tomography angiography for screening of hydroxychloroquine-induced retinal alterations.
    Bulut M, Akıdan M, Gözkaya O, Erol MK, Cengiz A, Çay HF.
    Graefes Arch Clin Exp Ophthalmol; 2018 Nov 01; 256(11):2075-2081. PubMed ID: 30159602
    [Abstract] [Full Text] [Related]

  • 16. Localization of damage in progressive hydroxychloroquine retinopathy on and off the drug: inner versus outer retina, parafovea versus peripheral fovea.
    de Sisternes L, Hu J, Rubin DL, Marmor MF.
    Invest Ophthalmol Vis Sci; 2015 May 01; 56(5):3415-26. PubMed ID: 26024126
    [Abstract] [Full Text] [Related]

  • 17. Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy.
    Michaelides M, Stover NB, Francis PJ, Weleber RG.
    Arch Ophthalmol; 2011 Jan 01; 129(1):30-9. PubMed ID: 21220626
    [Abstract] [Full Text] [Related]

  • 18. Imaging of Hydroxychloroquine Toxicity with Fluorescence Lifetime Imaging Ophthalmoscopy.
    Sauer L, Calvo CM, Vitale AS, Henrie N, Milliken CM, Bernstein PS.
    Ophthalmol Retina; 2019 Oct 01; 3(10):814-825. PubMed ID: 31345727
    [Abstract] [Full Text] [Related]

  • 19. Case Report: Hydroxychloroquine Retinopathy.
    Eldeeb M, Chan EW, Omar A.
    Optom Vis Sci; 2018 Jun 01; 95(6):545-549. PubMed ID: 29787487
    [Abstract] [Full Text] [Related]

  • 20. Visual Field Sensitivity Prediction Using Optical Coherence Tomography Analysis in Hydroxychloroquine Toxicity.
    Jayakar G, De Silva T, Cukras CA.
    Invest Ophthalmol Vis Sci; 2022 Jan 03; 63(1):15. PubMed ID: 35015028
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.